G 367 (Topiramate Extended-Release 25 mg)
Pill with imprint G 367 is Beige / Gray, Capsule-shape and has been identified as Topiramate Extended-Release 25 mg. It is supplied by Glenmark Pharmaceuticals Inc.
Topiramate is used in the treatment of epilepsy; lennox-gastaut syndrome; seizures; seizure prevention; migraine prevention and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for G 367
Topiramate Extended-Release
- Imprint
- G 367
- Strength
- 25 mg
- Color
- Beige / Gray
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Glenmark Pharmaceuticals Inc.
- National Drug Code (NDC)
- 68462-0372
Related Images for "G 367"
More about topiramate
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (1,220)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: carbonic anhydrase inhibitor anticonvulsants
Patient resources
- Drug Information
- Topiramate (Advanced Reading)
- Topiramate Extended-Release Capsules
- Topiramate Extended-Release Sprinkle Capsules
- Topiramate Tablets
- Topiramate Sprinkle Capsules
- Other brands
- Topamax, Trokendi XR, Topamax Sprinkle, Qudexy XR, ... +2 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.